Training Trauma Team Leaders With an Ambient AI Coach in Simulated Resuscitations
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT07930117. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Simulation Training With an Ambient AI Coach and Trauma Team Leader Performance
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The goal of this study is to learn whether simulation training with an ambient artificial-intelligence (AI) coach improves how physicians lead trauma resuscitations. The main question it aims to answer is: \- After coach-assisted training, do participants lead simulated trauma resuscitations without the coach better than they did before training? Researchers will compare each participant's performance on cases led without the coach before and after training. Participants will: * Lead simulated trauma resuscitations by voice in a trauma-bay simulator * Lead cases without the coach, then training cases with the coach, then further cases without the coach * Complete short surveys Blinded attending physicians score each case from a recording.
Study identification
- NCT ID
- NCT07930117
- Recruitment status
- Enrolling by invitation
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 10 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 1, 2026 (Estimated)
- Primary completion
- Feb 28, 2027 (Estimated)
- Completion
- Feb 28, 2027 (Estimated)
- Last update posted
- Nov 10, 2026
2026 – 2027
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Harvard Medical School | Boston | Massachusetts | 02115 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07930117, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 10, 2026 · Synced Nov 15, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.